Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification

BACKGROUND: Patient-derived xenograft (PDX) models are important tools in precision medicine and for the development of targeted therapies to treat cancer patients. This study aimed to evaluate our precision medicine strategy that integrates genomic profiling and preclinical drug-screening platforms...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Oh, Doo-Yi, Jung, Kyungsoo, Song, Ji-Young, Kim, Seokhwi, Shin, Sang, Kwon, Yong-Jun, Oh, Ensel, Park, Woong-Yang, Song, Sang Yong, Choi, Yoon-La
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5557466/
https://ncbi.nlm.nih.gov/pubmed/28806950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3525-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars